Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Corticosterone
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Corticosterone

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (678 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Where it fits in the MeSH classification

Broader topics
Pregnenediones; 11-Hydroxycorticosteroids
Narrower topics
18-Hydroxycorticosterone

Research landscape

PubMed indexes 28,390 records tagged with the MeSH heading “Corticosterone” (counts retrieved 2026-10-31). 2,644 of them (9.3%) were published from 2020 onward, and the busiest period so far is through 1999 with 14,290 records.

Reviews account for 528 records (1.9%) and meta-analyses for 10. Randomized controlled trials number 52 (0.2%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 14,290 records; 2000-2009: 5,448 records; 2010-2019: 6,008 records; 2020 onward: 2,644 records14,290through 19995,4482000-20096,0082010-20192,6442020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199914,290
2000-20095,448
2010-20196,008
2020 onward2,644
Share of records by publication typeReviews: 1.9 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.2 percentReviews1.9% (528)Meta-analyses0.0% (10)Randomized controlled trials0.2% (52)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 28,390 PubMed records
TypeRecordsShare
Reviews5281.9%
Meta-analyses100.0%
Randomized controlled trials520.2%

Method: PubMed query "Corticosterone"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
The stressed brain of humans and rodents
Joëls M, Karst H, Sarabdjitsingh RA
2018Review article
Design not recorded in structured metadata
148cc by
PMID 29575542 · DOI · PMC5969253
Structural basis of organic cation transporter-3 inhibition
Khanppnavar B, Maier J, Herborg F, Gradisch R, Lazzarin E, Luethi D, et al.
2022Research article
Design not recorded in structured metadata
73cc by
PMID 36344565 · DOI · PMC9640557
Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice
Dieterich A, Srivastava P, Sharif A, Stech K, Floeder J, Yohn SE, et al.
2019Research article
Design not recorded in structured metadata
66cc by
PMID 31822658 · DOI · PMC6904464
Corticosterone Under Experimental Manipulation of Nutrition and Parasite Burden in a Wild Rodent System
Wolf SE, Dłużniewska O, Babayan SA, Pedersen AB, Little TJ
2026Research article
Design not recorded in structured metadata
0cc by
PMID 42337970 · DOI · PMC13353635

The stressed brain of humans and rodents [1]

Review article Joëls M, Karst H, Sarabdjitsingh RA · · 2018 · cited 148 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
After stress, the brain is exposed to waves of stress mediators, including corticosterone (in rodents) and cortisol (in humans).
Closing excerpt
Studies in rodents point to the possibility to prevent or reverse long-term consequences of early life adversity on cognitive processing, by normalizing the balance between the two receptor types for corticosteroid hormones at a critical moment just before the onset of puberty.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (191 words)

After stress, the brain is exposed to waves of stress mediators, including corticosterone (in rodents) and cortisol (in humans). Corticosteroid hormones affect neuronal physiology in two time-domains: rapid, non-genomic actions primarily via mineralocorticoid receptors; and delayed genomic effects via glucocorticoid receptors. In parallel, cognitive processing is affected by stress hormones. Directly after stress, emotional behaviour involving the amygdala is strongly facilitated with cognitively a strong emphasis on the "now" and "self," at the cost of higher cognitive processing. This enables the organism to quickly and adequately respond to the situation at hand. Several hours later, emotional circuits are dampened while functions related to the prefrontal cortex and hippocampus are promoted. This allows the individual to rationalize the stressful event and place it in the right context, which is beneficial in the long run. The brain's response to stress depends on an individual's genetic background in interaction with life events. Studies in rodents point to the possibility to prevent or reverse long-term consequences of early life adversity on cognitive processing, by normalizing the balance between the two receptor types for corticosteroid hormones at a critical moment just before the onset of puberty.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29575542 · DOI · PMC5969253

Structural basis of organic cation transporter-3 inhibition [2]

Research article Khanppnavar B, Maier J, Herborg F, Gradisch R, Lazzarin E, Luethi D, et al. · · 2022 · cited 73 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Organic cation transporters (OCTs) facilitate the translocation of catecholamines, drugs and xenobiotics across the plasma membrane in various tissues throughout the human body.
Closing excerpt
In addition, we relate the functional characteristics of an extensive collection of previously uncharacterized human genetic variants to structural features, thereby providing a basis for understanding the impact of OCT3 polymorphisms.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (132 words)

Organic cation transporters (OCTs) facilitate the translocation of catecholamines, drugs and xenobiotics across the plasma membrane in various tissues throughout the human body. OCT3 plays a key role in low-affinity, high-capacity uptake of monoamines in most tissues including heart, brain and liver. Its deregulation plays a role in diseases. Despite its importance, the structural basis of OCT3 function and its inhibition has remained enigmatic. Here we describe the cryo-EM structure of human OCT3 at 3.2 Å resolution. Structures of OCT3 bound to two inhibitors, corticosterone and decynium-22, define the ligand binding pocket and reveal common features of major facilitator transporter inhibitors. In addition, we relate the functional characteristics of an extensive collection of previously uncharacterized human genetic variants to structural features, thereby providing a basis for understanding the impact of OCT3 polymorphisms.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36344565 · DOI · PMC9640557

Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice [3]

Research article Dieterich A, Srivastava P, Sharif A, Stech K, Floeder J, Yohn SE, et al. · · 2019 · cited 66 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Behavioral approaches utilizing rodents to study mood disorders have focused primarily on negative valence behaviors associated with potential threat (anxiety-related behaviors).
Closing excerpt
These data suggest that CORT administration is a useful experimental system for preclinical approaches to studying stress-induced mood disorders.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (186 words)

Behavioral approaches utilizing rodents to study mood disorders have focused primarily on negative valence behaviors associated with potential threat (anxiety-related behaviors). However, for disorders such as depression, positive valence behaviors that assess reward processing may be more translationally valid and predictive of antidepressant treatment outcome. Chronic corticosterone (CORT) administration is a well-validated pharmacological stressor that increases avoidance in negative valence behaviors associated with anxiety1-4. However, whether chronic stress paradigms such as CORT administration also lead to deficits in positive valence behaviors remains unclear. We treated male C57BL/6J mice with chronic CORT and assessed both negative and positive valence behaviors. We found that CORT induced avoidance in the open field and NSF. Interestingly, CORT also impaired instrumental acquisition, reduced sensitivity to a devalued outcome, reduced breakpoint in progressive ratio, and impaired performance in probabilistic reversal learning. Taken together, these results demonstrate that chronic CORT administration at the same dosage both induces avoidance in negative valence behaviors associated with anxiety and impairs positive valence behaviors associated with reward processing. These data suggest that CORT administration is a useful experimental system for preclinical approaches to studying stress-induced mood disorders.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 31822658 · DOI · PMC6904464

Corticosterone Under Experimental Manipulation of Nutrition and Parasite Burden in a Wild Rodent System [4]

Research article Wolf SE, Dłużniewska O, Babayan SA, Pedersen AB, Little TJ · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Environmental pressures shape survival and life-history dynamics partly by triggering the release of glucocorticoids, whose short-term benefits but long-term costs make it essential to understand what drives their levels.
Closing excerpt
Thus, alleviating some environmental stressors in the wild may have unintended consequences on host fitness.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (169 words)

Environmental pressures shape survival and life-history dynamics partly by triggering the release of glucocorticoids, whose short-term benefits but long-term costs make it essential to understand what drives their levels. Here, we used an experimental manipulation of two environmental stressors-food availability and parasite burden-to directly test how they influence fecal corticosterone metabolites (FCMs) in wild wood mice (Apodemus sylvaticus). To do so, we experimentally altered nutrition via high-quality food supplementation and reduced gastrointestinal nematode infection by anthelmintic treatment, using Heligmosomoides polygyrus as an indicator of treatment efficacy. FCM levels were not impacted by either treatment. However, our results may be mediated by variation in resource availability or masked by other factors that affect corticosterone. For example, FCMs declined seasonally, alongside a decline in the number of reproducing individuals. While we expected higher food availability and lower worm burdens to decrease stress, putatively higher rates of reproduction in food-supplemented areas may offset potential declines in corticosterone. Thus, alleviating some environmental stressors in the wild may have unintended consequences on host fitness.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42337970 · DOI · PMC13353635

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Non-invasive measurement of glucocorticoids: Advances and problems [5]
    Palme R · Physiol Behav · 2019 · cited 374 times (Europe PMC)
  • Research article Rapid non-genomic effects of corticosteroids and their role in the central stress response [6]
    Groeneweg FL, Karst H, de Kloet ER, Joëls M · J Endocrinol · 2011 · cited 304 times (Europe PMC)
  • Research article Stress-induced augmentation of immune function--the role of stress hormones, leukocyte trafficking, and cytokines [7]
    Dhabhar FS · Brain Behav Immun · 2002 · cited 280 times (Europe PMC)
  • Research article Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation [8]
    Schaaf MJ, De Kloet ER, Vreugdenhil E · Stress · 2000 · cited 205 times (Europe PMC)
  • Research article Stress response and the value of reproduction: are birds prudent parents? [9]
    Bókony V, Lendvai AZ, Liker A, Angelier F, Wingfield JC, Chastel O · Am Nat · 2009 · cited 191 times (Europe PMC)
  • Research article Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance [10]
    Leibowitz SF · Neurosci Biobehav Rev · 1988 · cited 167 times (Europe PMC)

References

  1. Joëls M, Karst H, Sarabdjitsingh RA. The stressed brain of humans and rodents. . 2018. PMID 29575542 · DOI · PMC5969253
  2. Khanppnavar B, Maier J, Herborg F, Gradisch R, Lazzarin E, Luethi D, et al.. Structural basis of organic cation transporter-3 inhibition. . 2022. PMID 36344565 · DOI · PMC9640557
  3. Dieterich A, Srivastava P, Sharif A, Stech K, Floeder J, Yohn SE, et al.. Chronic corticosterone administration induces negative valence and impairs positive valence behaviors in mice. . 2019. PMID 31822658 · DOI · PMC6904464
  4. Wolf SE, Dłużniewska O, Babayan SA, Pedersen AB, Little TJ. Corticosterone Under Experimental Manipulation of Nutrition and Parasite Burden in a Wild Rodent System. . 2026. PMID 42337970 · DOI · PMC13353635
  5. Palme R. Non-invasive measurement of glucocorticoids: Advances and problems. Physiol Behav. 2019. PMID 30468744 · DOI
  6. Groeneweg FL, Karst H, de Kloet ER, Joëls M. Rapid non-genomic effects of corticosteroids and their role in the central stress response. J Endocrinol. 2011. PMID 21357682 · DOI
  7. Dhabhar FS. Stress-induced augmentation of immune function--the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav Immun. 2002. PMID 12480507 · DOI
  8. Schaaf MJ, De Kloet ER, Vreugdenhil E. Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress. 2000. PMID 10938581 · DOI
  9. Bókony V, Lendvai AZ, Liker A, Angelier F, Wingfield JC, Chastel O. Stress response and the value of reproduction: are birds prudent parents?. Am Nat. 2009. PMID 19281425 · DOI
  10. Leibowitz SF. Hypothalamic paraventricular nucleus: interaction between alpha 2-noradrenergic system and circulating hormones and nutrients in relation to energy balance. Neurosci Biobehav Rev. 1988. PMID 2845312 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • AldosteroneDrugs and Chemicals
  • AndrostenedioneDrugs and Chemicals
  • CortisoneDrugs and Chemicals
  • DehydroepiandrosteroneDrugs and Chemicals
  • Dehydroepiandrosterone SulfateDrugs and Chemicals
  • EstroneDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

28,390
PubMed records on this heading
9%
published since 2020
528
review articles
52
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • AldosteroneDrugs and Chemicals
  • AndrostenedioneDrugs and Chemicals
  • CortisoneDrugs and Chemicals
  • DehydroepiandrosteroneDrugs and Chemicals
  • Dehydroepiandrosterone SulfateDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support